In 2023, the market size value per capita for hormones in dosage except contraceptives and antibiotics in Guatemala stood at $3.66, showing a progressive increase over a decade. The year-on-year growth from 2022 to 2023 was approximately 2.23%. The compound annual growth rate (CAGR) for the last five years was around 2.57%. This indicates a consistent upward trend with slight fluctuations, such as in 2022.
Future trends to watch for include increased demand driven by healthcare improvements and demographic shifts, as well as the potential impact of regulatory changes or economic conditions that could either bolster or impede market growth. Monitoring these factors will be crucial for stakeholders in the industry.
